HMGA1 and neoplasm: Up to date, although several genes have been implicated as subtype-specific diagnostic markers and therapeutic targets for BCa metastasis (e.g., HMGA1 and CDCA7 for TNBC metastasis [25, 26]), universal target genes for diagnosis and treatment of tumor metastasis in multiple subtypes of BCa are still required.